Mason Street Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-52,988
Closed -$4.9M 366
2020
Q4
$4.9M Sell
52,988
-800
-1% -$71.4K 0.08% 222
2020
Q3
$5.54M Buy
53,788
+1,080
+2% +$113K 0.11% 169
2020
Q2
$5.34M Buy
+52,708
New +$4.71M 0.11% 165
2015
Q1
Sell
-553,060
Closed -$7.61M 1575
2014
Q4
$7.61M Sell
553,060
-43,680
-7% -$535K 0.05% 397
2014
Q3
$5.97M Hold
596,740
0.05% 450
2014
Q2
$5.92M Sell
596,740
-16,300
-3% -$144K 0.05% 465
2014
Q1
$6.34M Sell
613,040
-13,720
-2% -$142K 0.05% 420
2013
Q4
$5.55M Sell
626,760
-174,440
-22% -$1.38M 0.05% 467
2013
Q3
$5.65M Buy
801,200
+267,032
+50% +$1.69M 0.06% 329
2013
Q2
$3M Buy
+534,168
New +$2.56M 0.03% 545

Other funds holding DXCM

Mason Street Advisors's DXCM Position: Q1 2021 in Review

Mason Street Advisors sold out of DexCom (DXCM) in Q1 2021, closing a stake of 52,988 shares — an estimated $4.9M sold.

Mason Street Advisors first reported a position in DXCM in Q2 2013 and held it in 10 quarters. The position peaked at $7.61M in Q4 2014. 730 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

  • Mason Street Advisors reported no remaining DexCom position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 52,988 DexCom shares in Q1 2021, an estimated $4.9M.
  • Mason Street Advisors first reported a position in DexCom in Q2 2013 and held it in 10 quarters.
  • Mason Street Advisors's DexCom position peaked at $7.61M in Q4 2014.
  • 730 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.